A State of Revision: USP's Guideline for the Submission of Requests for Revision

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2003
Volume 27
Issue 12

USP's new guideline will assist the industry to help set the monograph standards by which the industry must abide. This column suggests how to apply the guideline to gain maximum benefit.

External Link - article-78319.pdf

Articles in this issue
December 2003
All Signs Indicate a Strong 2004 for Contract Services
Behavior of Uptake of Moisture by Drugs and Excipients
A State of Revision: USP's Guideline for the Submission of Requests for Revision
Targeted Cationic Liposomes, Technologies, and Developments
Sixth Annual International Employment Survey: Staying the Course
Drug Pricing Concerns Shape Policy Decisions in 2003
In the Spotlight--January 2004
December 2003
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novartis to Expand US-Based R&D and Manufacturing

Susan Haigney
April 11th 2025
Article

The company has plans to invest $23 billion during the next five years to expand manufacturing and R&D in the US, which will include seven new facilities.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Siemens Acquires Dotmatics, Extending AI Software Portfolio into Life Sciences

Patrick Lavery
April 9th 2025
Article

Siemens said spending on AI software is predicted to double by the end of the 2020s, in a market increasingly driven by structural shifts that underscore a need for digital transformation.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Agentic AI Growth Predicted, but More Than Half of Pharma Still Resisting Change: Report

Patrick Lavery
April 8th 2025
Article

Lack of skills in the AI realm was a distant second among those surveyed about the biggest barrier to innovation while using the technology.

Blue Paper Boat Leading A Fleet Of Small White Boats With Compass Icon On Grey Concrete - Leadership Concept | Image Credit: ©Philip Steury -stock.adobe.com

Navigating the Complexities of Emerging Therapy Development

Cynthia A. Challener
April 8th 2025
Article

Advancement of emerging therapies faces hurdles across all aspects and phases of drug development and manufacturing.